Anti-metastatic effect of supercritical extracts from the Citrus hassaku pericarp via inhibition of C-X-C chemokine receptor type 4 (CXCR4) and matrix metalloproteinase-9 (MMP-9)

Phytotherapy Research

Volumn 28, Issue 9, 2014, Pages 1374-1382

  Kim, Chulwon ^a   Kim, Dongmin ^a   Nam, Dongwoo ^a   Chung, Won Seok ^a   Ahn, Kyoo Seok ^a   Kim, Sung Hoon ^a   Choi, Seung Hoon ^a   Shim, Bum Sang ^a   Cho, Somi K ^b   Ahn, Kwang Seok ^a  

^a Kyung Hee University   (South Korea)

^b Jeju National University   (South Korea)

Author keywords

Citrus hassaku Hort. ex Tanaka; CXCR4; Metastasis; MMP 9; NF B

Indexed keywords

9 OCTADECENAL; ANTIMETASTATIC AGENT; CHEMOKINE RECEPTOR CXCR4; CITRUS HASSAKU EXTRACT; FLAVONOID; GELATINASE B; HEXADECANEDIOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIMONENE; LINALOOL; MESSENGER RNA; PLANT EXTRACT; STIGMASTEROL; STROMAL CELL DERIVED FACTOR 1; TERPINENE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CXCR4 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; RELA PROTEIN, HUMAN;

ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CHROMATIN IMMUNOPRECIPITATION; CITRUS FRUIT; CITRUS HASSAKU; CONCENTRATION RESPONSE; CONTROLLED STUDY; CXCR4 GENE; DOWN REGULATION; DRUG EFFECT; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; METASTASIS INHIBITION; MMP 9 GENE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUPERCRITICAL FLUID EXTRACTION; TRANSCRIPTION REGULATION; BREAST TUMOR; CELL MOTION; CHEMISTRY; CITRUS; CITRUS HASSAKU HORT. EX TANAKA; CXCR4; FEMALE; FRUIT; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; MMP-9; NF-ΚB; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CITRUS HASSAKU HORT. EX TANAKA; CXCR4; METASTASIS; MMP-9; NF-ΚB;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CITRUS; FEMALE; FRUIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PLANT EXTRACTS; RECEPTORS, CXCR4; TRANSCRIPTION FACTOR RELA;

EID: 84907899890     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5140     Document Type: Article

References (46)

1. Baek SH, Kim SM, Nam D, et al. 2012. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9. Pharm Biol 50: 1210-1218.
2. Balkwill F. 2004. Cancer and the chemokine network. Nat Rev Cancer 4: 540-550.
3. Bhandari D, Trejo J, Benovic JL, Marchese A. 2007. Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem 282: 36971-36979.
4. Bogenrieder T, Herlyn M. 2003. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22: 6524-6536.
5. Brummer O, Athar S, Riethdorf L, Loning T, Herbst H. 1999. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch 435: 566-573.
6. Cimino F, Cristani M, Saija A, Bonina FP, Virgili F. 2007. Protective effects of a red orange extract on UVB-induced damage in human keratinocytes. Biofactors 30: 129-138.
7. Cox G, O'Byrne KJ. 2001. Matrix metalloproteinases and cancer. Anticancer Res 21: 4207-4219.
8. Day JD, Digiuseppe JA, Yeo C, et al. 1996. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 27: 119-124.
9. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161- 174.
10. Fernandis AZ, Prasad A, Band H, Klosel R, Ganju RK. 2004. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23: 157-167.
11. Fidler IJ. 1989. Origin and biology of cancer metastasis. Cytometry 10: 673-680.
12. Gschwind A, Prenzel N, Ullrich A. 2002. Lysophosphatidic acidinduced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res 62: 6329-6336.
13. Gupta PB, Mani S, Yang J, Hartwell K, Weinberg RA. 2005. The evolving portrait of cancer metastasis. Cold Spring Harb Symp Quant Biol 70: 291-297.
14. Helbig G, Christopherson KW, 2nd, Bhat-Nakshatri P, et al. 2003. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638.
15. Hernandez PA, Gorlin RJ, Lukens JN, et al. 2003. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34: 70-74.
16. Hosoda K, Noguchi M. 1989. Studies on the preparation and evaluation of Kijitsu, the immature citrus fruits. II. Analysis of factors which affect the flavonoid contents. Yakugaku Zasshi 109: 560-563.
17. Hosoda K, Noguchi M, Chen YP, Hsu HY. 1991. Studies on the preparation and evaluation of Kijitsu, the immature citrus fruits. IV. Biological activities of immature fruits of different citrus species. Yakugaku Zasshi 111: 188-192.
18. Itoh K, Hirata N, Masuda M, et al. 2009a. Inhibitory effects of Citrus hassaku extract and its flavanone glycosides on melanogenesis. Biol Pharm Bull 32: 410-415.
19. Itoh K, Masuda M, Naruto S, Murata K, Matsuda H. 2009b. Antiallergic activity of unripe Citrus hassaku fruits extract and its flavanone glycosides on chemical substance-induced dermatitis in mice. J Nat Med 63: 443-450.
20. Jung KH, Ha E, Kim MJ, et al. 2007. Suppressive effects of nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression by Citrus reticulata extract in RAW 264.7 macrophage cells. Food Chem Toxicol 45: 1545-1550.
21. Kim JA, Park HS, Kang SR, et al. 2012. Suppressive effect of flavonoids from Korean Citrus aurantium L. on the expression of inflammatory mediators in L6 skeletal muscle cells. Phytother Res 26: 1904-1912.
22. Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ES. 2004. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 50: 87-100.
23. Knaut H, Werz C, Geisler R, Nusslein-Volhard C. 2003. A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor. Nature 421: 279-282.
24. Kruizinga RC, Bestebroer J, Berghuis P, et al. 2009. Role of chemokines and their receptors in cancer. Curr Pharm Des 15: 3396-3416.
25. Leivonen SK, Kahari VM. 2007. Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 121: 2119-2124.
26. Li YM, Pan Y, Wei Y, et al. 2004. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6: 459-469.
27. Liotta LA, Steeg PS, Stetler-Stevenson WG. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64; 327-336.
28. Muller A, Homey B, Soto H, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
29. Murphy PM. 2001. Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345: 833-835.
30. Nagasawa T, Hirota S, Tachibana K, et al. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635-638.
31. Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274: 21491-21494.
32. Porcile C, Bajetto A, Barbero S, Pirani P, Schettini G. 2004. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Ann N Y Acad Sci 1030: 162-169.
33. Pratheeshkumar P, Raphael TJ, Kuttan G. 2012. Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells. Integr Cancer Ther 11: 48- 60.
34. Proudfoot AE. 2002. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2: 106-115.
35. Raman D, Baugher PJ, Thu YM, Richmond A. 2007. Role of chemokines in tumor growth. Cancer Lett 256: 137-165.
36. Scarlatti G, Tresoldi E, Bjorndal A, et al. 1997. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3: 1259-1265.
37. Smith MC, Luker KE, Garbow JR, et al. 2004. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612.
38. Steeg PS. 2003. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3: 55-63.
39. Taichman RS, Cooper C, Keller ET, et al. 2002. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62, 1832-1837.
40. Tanaka T, Kohno H, Murakami M, Kagami S, El-Bayoumy K. 2000. Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis(methylene)selenocyanate and the Citrus antioxidant auraptene on lung metastasis of melanoma cells in mice. Cancer Res 60: 3713-3716.
41. Tanaka T, Yasui Y, Ishigamori-Suzuki R, Oyama T. 2008. Citrus compounds inhibit inflammation- and obesity-related colon carcinogenesis in mice. Nutr Cancer 60(Suppl 1): 70-80.
42. Tang Q, Ding Q, Lin L, Zhang ZZ, Dai Z, Zhan JB. 2012. Development of antibody drugs targeting against HER2 for cancer therapy. Yao Xue Xue Bao 47: 1297-1305.
43. Uchida D, Begum NM, Almofti A, et al. 2003. Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 290: 289-302.
44. Vihinen P, Kahari VM. 2002. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99: 157-166.
45. Westermarck J, Kahari VM. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13: 781-792.
46. Yang J, Mani SA, Donaher JL, et al. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939.